论文部分内容阅读
你以为,违规的只是GSK一家?“GSK新闻发言人无法回避后承认,此前的举报人已经是第二次寄送材料。”GSK涉嫌在华推广产品时向医生许诺回扣。“这句话不过是这家全球第三大制药商的经营潜规则中露出的冰山一角。”目前,事情最新的进展是,在“GSK中国四驾马车”全部被捕之后,总部已经派出三名高管前往中国,处理与涉贿调查有关的问题。且中国有关部门已逮捕一名英国公民,该公民很可能是一位商业竞争情报顾问人员。GSK并非跨国公司在华行贿的个案。就在医药领域,2008年的西门子案,2012年的辉瑞制药案,足以让
Do you think that the violation is only a GSK one? “ GSK news spokesman can not be avoided and admitted that the previous whistleblower is already the second time to send the material. ” GSK suspected of promoting the product in China to the doctor promised a rebate. “This sentence is just the tip of the iceberg that emerged from the unspoken rules of the world’s third-largest pharmaceutical company.” “Currently, the latest development in this matter is after the arrest of the ”GSK China Troika". The headquarters has sent three executives to China to handle issues related to bribery investigations. And China’s relevant authorities have arrested a British citizen who is likely to be a commercial competitive intelligence consultant. GSK is not a case of a multinational company bribing in China. In the medical field, the Siemens case in 2008 and the Pfizer case in 2012 were enough to make